Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.
about
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.
@en
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.
@nl
type
label
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.
@en
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.
@nl
prefLabel
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.
@en
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.
@nl
P2093
P2860
P1476
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis
@en
P2093
Jian Zhang
Jiefeng Luo
Shengliang Shi
Xiaobo Yang
Yousheng Xiao
Yueling Zhang
P2860
P304
P356
10.1002/14651858.CD010968.PUB2
P577
2017-11-27T00:00:00Z